Notes for P&L
Note 55 Personnel options
During the year, the company entered into related party transactions in connection with the implementation of the Employee Stock Option Program 2025/2028 and Employee Stock Option Program 2025/2029. Allotment agreements were entered into between the company and key employees under the Employee Stock Option Program 2025/2028. Similarly, allotment agreements were also entered into between the company and members of the Board of Directors under the Employee Stock Option Program 2025/2029. These agreements were entered into on market terms and in accordance with the resolutions adopted by the Annual General Meeting held on June 24, 2025. Under the Employee Stock Option Program 2025/2028, a total of 265,569 options were allotted without consideration. Under the Employee Stock Option Program 2025/2029, a total of 113,813 options were allotted without consideration.
Calculations of the fair value for long-term incentive programs are based on the Black and Scholes method. The fair value of the allocated option is reported as a cost for compensation to employees with a corresponding increase in equity. Cost relating to the employee stock option program for the board and employees amounted to 0.8 MSEK. Main terms of the programs are summarized below:
Main terms of the Employee Stock Option Program 2025/2028
- Allotted ESOPs are subject to vesting, whereby one third of the allotted ESOPs will vest on each of 1 September
2026, 2027, and 2028. - If a participant’s employment with FPC is terminated during the vesting period, the ESOPs will, as a main rule, lapse. However, there are certain exceptions (“Good Leaver situations”) where only the non-vested part of the ESOPs will lapse. Examples of Good Leaver situations are termination due to the participants retirement, severe illness, death, and termination due to redundancy.
- Vested ESOPs can be exercised between 1 September 2028 and 1 November 2028, if the strike price is met.
- The strike price will be equal to 150 percent of the share price following the record date of the consolidation. This means that participants will receive no benefit from the plan, unless the share price increases by at least 50 percent.
Main terms of the Employee Stock Option Program 2025/2029
- Allotted ESOPs are subject to vesting, whereby one fourth of the allotted ESOPs will vest on each of 1
September 2026, 2027, 2028, and 2029. - If a participant’s directorship with Fingerprints ends during the vesting period, the ESOPs will, as a main rule, lapse. However, there are certain exceptions (“Good Leaver situations”) where only the non-vested part of the ESOPs will lapse. Examples of Good Leaver situations are the participants retirement, severe illness, or death.
- Vested ESOPs can be exercised between 1 September 2029 and 1 November 2029, if the strike price is met.
- The strike price will be equal to 175 percent of the share price following the record date of the consolidation. This means that participants will receive no benefit from the plan, unless the share price increases by at least 75 percent.
| Employee program | ||
|---|---|---|
| Weighted average exercise price | Number | |
| Outstanding at 1 January 2025 | - | - |
| Granted during the year | 34.26 | 265,596 |
| Forfeited during the year | - | - |
| Lapsed during the year | - | - |
| - | - | |
| Outstanding at 31 December 2025 | 34.26 | 265,596 |
| Board program | ||
|---|---|---|
| Weighted average exercise price | Number | |
| Outstanding at 1 January 2025 | - | - |
| Granted during the year | 39.97 | 113,815 |
| Forfeited during the year | - | - |
| Lapsed during the year | - | - |
| - | - | |
| Outstanding at 31 December 2025 | 39.97 | 113,815 |